UNSPSC 51131701: Abciximab

This classification denotes a monoclonal antibody with the molecular formula C2101H3229N551O673S15, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X85G7936GV, more generally known as abciximab. European Medicines Agency schedules abciximab in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00233MIG. The term ABCIXIMAB is an International Non-Proprietary Name or INN. see WHO INN reference publication, Volume 13 no. 1, 1999, list 41.

ABCIXIMAB is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule abciximab under HS 30021091 and SITC 54163. As of Q4 2014, ABCIXIMAB remains the US FDA Preferred Term for this commodity. Abciximab bears US NLM identifiers UMLS ID C0288672 and NCI Concept Code C76128. SMILES: NONE.

UNSPSC 51131701 Abciximab is a Commodity code that designates a specific pharmaceutical product — a monoclonal antibody used in acute coronary syndrome treatment — yet the only recent state and local solicitation tagged to this code shows a fundamental mismatch: Sourcewell, a Minnesota local government unit and service cooperative, posted RFP #061626 on May 12, 2026 (due June 16, 2026) for Law Enforcement Equipment, not pharmaceutical procurement. The solicitation establishes a cooperative purchasing vehicle for law enforcement goods across thousands of governmental agencies, higher education institutions, K-12 school districts, nonprofit organizations, tribal governments, and other public entities throughout the United States and Canada. The mismatch between the code's pharmaceutical scope and the actual law enforcement equipment scope signals that this code shows little relevant recent state and local activity under its nominal designation.

The single recent opportunity tagged to UNSPSC 51131701 reflects Sourcewell's cooperative purchasing model rather than Abciximab procurement. Sourcewell, operating under Washington state law (RCW 39.34), drew participation from Franklin County, Grant County, Grays Harbor County, Chelan County, and Yakima County as anchor jurisdictions, with the contract vehicle available to a national and Canadian scope of public entities. Submissions required portal access at https://proportal.sourcewell-mn.gov by June 16, 2026 at 3:30 p.m. Central Time, with contact at rfp@sourcewell-mn.gov or 888-894-1930. The solicitation posted no explicit set-aside designations, incumbent vendor information, or award values. The absence of pharmaceutical-specific solicitations under this code suggests that state and local Abciximab procurement, if occurring, routes through different purchasing channels, group purchasing organizations, or higher-tier healthcare systems rather than through direct RFP activity visible in this dataset.